Colorectal cancer with synchronous liver metastases - Boudiaf, Zaki
55,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
28 °P sammeln
  • Broschiertes Buch

Colorectal cancer is the leading digestive cancer worldwide. The liver is the most frequent site of colorectal cancer metastases. During the course of the disease, 40 to 60% of patients will develop liver metastases, which are synchronous in 10 to 25% of cases.Elective surgery is the only potentially curative treatment.In the synchronous situation, the simultaneous surgical approach has been validated, but poses a problem of approach.Laparoscopy may have a place in this approach.The aim of our study was to assess the feasibility and safety of the laparoscopic approach in combined surgery for colorectal cancer with synchronous liver metastases.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Colorectal cancer is the leading digestive cancer worldwide. The liver is the most frequent site of colorectal cancer metastases. During the course of the disease, 40 to 60% of patients will develop liver metastases, which are synchronous in 10 to 25% of cases.Elective surgery is the only potentially curative treatment.In the synchronous situation, the simultaneous surgical approach has been validated, but poses a problem of approach.Laparoscopy may have a place in this approach.The aim of our study was to assess the feasibility and safety of the laparoscopic approach in combined surgery for colorectal cancer with synchronous liver metastases.
Autorenporträt
A digestive oncological surgeon working at the Pierre and Marie Curie Center in Algiers, he is also an associate professor in general surgery, teaching at the Faculty of Medicine in Algiers, and author of several publications in the field of digestive oncological surgery, particularly laparoscopic surgery.